rediff.com
India As It Happens
India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
rediff News App
Hi Guest
About 291 results for "ranbaxy lab"
 |
Ranbaxy shares recover, gain 4%Home/MARKETS /Stock Watch /Story Tags: Ranbaxy Lab | Ranbaxy shares | US lawsuit setllement Shares of Ranbaxy Laboratories recovered from early losses and settled nearly 4 per cent higher on hopes that settlement of its long lawsuit in the US ... Business Today India, 3 days ago |
See all (21) images for "ranbaxy lab" | ||||
See all (21) images for "ranbaxy lab"
Moneycontrol.com
|
Ranbaxy Lab drops as base effect pulls Q1 net profit lowerRanbaxy Laboratories lost 1.42% to Rs 450 at 14:23 IST on BSE after consolidated net profit declined 89.91% to Rs 125.75 crore on 33.29% decline in total income to Rs 2562.96 crore in Q1 March 2013 over Q1 March 2012. The company announced Q1 ... India Infoline, 1 week ago
Ranbaxy Lab drops after Q1 numbers
Business Standard, 1 week ago
Weakness prevails in Ranbaxy Labs counter
India Infoline, 1 week ago
Ranbaxy net dips 90% on losing Lipitor generic
Financial Chronicle, 1 week ago
|
Ranbaxy Lab reverses early slide on settlement with US regulatorRanbaxy Laboratories gained 3.51% to Rs 455 at 15:10 IST on BSE, reversing early slide, on optimism the company can now focus on improving core business operations following settlement of criminal and civil lawsuit with the US government. Meanwhile, ... India Infoline, 4 days ago
|
Ranbaxy Lab gains on settlement with US regulatorRanbaxy Laboratories has moved higher by 3.4% at Rs 455, bouncing back 8% from day’s low after the pharmaceutical company has agreed to pay $500 million (approximately Rs 2,743 crore) to resolve fraud allegations that the company sold adulterated drugs ... Business Standard, 4 days ago
|
Ranbaxy Lab slips on disappointing Q1 earningsRanbaxy Laboratories has dipped 3% to Rs 443, in otherwise firm market, on reporting a sharp 90% year-on-year decline in its consolidated net profit at Rs 126 crore for the first quarter ended March 31, 2013 (Q1) due to the base effect. Business Standard, 1 week ago
Ranbaxy Lab falls on disappointing Q1 earnings
Business Standard, 1 week ago
Ranbaxy net profit plunges 90%
Smart Investor, 1 week ago
|
Moneycontrol.com
|
Ranbaxy: Updates on investigation by US Department of JusticeRanbaxy Laboratories Ltd has informed BSE regarding a Press Release dated May 13, 2013 titled "Ranbaxy announces conclusion of previously disclosed investigation by U.S. Department of Justice".Source : BSE Read all announcements in Ranbaxy Labs var ... Moneycontrol.com, 4 days ago
Ranbaxy pleads guilty to felony charges, to pay $500 mn | Live price
Economic Times, 4 days ago
Ranbaxy Labs whistleblower to get Rs266cr!
DNA, 4 days ago
Ranbaxy Announces Conclusion of Previously Disclosed Investigation by U.S. Department of Justice
Individual.com, 4 days ago
|
|
Money Control
|
Centrum maintains 'sell' rating on Ranbaxy, target Rs 400Related to : Ranbaxy Laboratories Ltd Ranbaxy Laboratories Ltd BSE 13 May 13 | 09:37 AM 447.00 -1.95 (-0.43%) NSE 13 May 13 | 09:30 AM 447.25 -1.7 (-0.38%) Ranbaxy Labs results for the first quarter (Jan-Mar) of 2013 were below our expectations. Smart Investor, 5 days ago
Karvy reiterates 'buy' on Ranbaxy, target Rs 524
Smart Investor, 1 week ago
Sell Ranbaxy Laboratories with a target of Rs 427: CK Narayan
Economic Times, 1 week ago
Short Ranbaxy Labs with a target of Rs 418: Bhamre
Money Control, 1 month ago
|
Money Control
|
Sensex consolidates; Ranbaxy recovers 7% from day's lowKey equity benchmarks were consolidating today after shedding close to 2 percent Monday on widening trade deficit data that renewed concerns of India's current account deficit. The Sensex was up 21 points at 19713 and the Nifty was up 10 points at ... Moneycontrol.com, 4 days ago
Go Long on Federal Bank, Hindalco:Mudit Goyal
Smart Investor, 3 days ago
Sensex ends flat, shrugs off 41-month low inflation data
Money Control, 4 days ago
Sensex flat; HCL Tech, JP Associates, BHEL top losers
Moneycontrol.com, 4 days ago
|
Ranbaxy systematically violated good manufacturing practices, says whistleblowerRanbaxy Laboratories systemically violated good manufacturing practices, says the whisteblower whose alert led to a US probe, a day after India's top drugmaker agreed to pay a hefty $500 million to settle charges over its adulterated drugs. The ... New Delhi Pioneer, 3 days ago
|
Ranbaxy settles US case for $500 mn, shares spurt 3.6%Shares of drug maker Ranbaxy Laboratories ended 3.6% up at Rs. 455.50 on Tuesday after crashing 4% in early trade on the Bombay Stock Exchange following a $500-million (about Rs. 2,750 crore) fine imposed by US authorities on the company for selling ... Hindustan Times, 3 days ago
Ranbaxy settles US case for 500 mn shares spurt 36
Hindustan Times, 3 days ago
|
Prev
| Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
►AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts
rediff News App
Alerts
Get updated on latest news & your favorite topics right in your inbox!
Widget
Get Realtime News on your webpage & get your members hooked!
Happening by Location
Click on any location on map to view latest news by location
